Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访

2020-11-12 欧洲肿瘤内科学会 Ann Oncol . 2020 Nov 12;

骨髓增生异常综合征

2020年11月，欧洲肿瘤内科学会(ESMO)发布了骨髓增生异常综合征的诊断，治疗和随访指南。指南主要内容涉及骨髓增生异常综合征的发病率和流行病学，诊断、病理/分子诊断，分期和危险分层，治疗，个体化医

中文标题：

2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访

英文标题：

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-11-12

简要介绍：

2020年11月，欧洲肿瘤内科学会(ESMO)发布了骨髓增生异常综合征的诊断，治疗和随访指南。指南主要内容涉及骨髓增生异常综合征的发病率和流行病学，诊断、病理/分子诊断，分期和危险分层，治疗，个体化医疗以及随访等。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=75aff1c00201e7f3, title=2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访, enTitle=Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, guiderFrom=Ann Oncol . 2020 Nov 12;, authorId=0, author=, summary=2020年11月，欧洲肿瘤内科学会(ESMO)发布了骨髓增生异常综合征的诊断，治疗和随访指南。指南主要内容涉及骨髓增生异常综合征的发病率和流行病学，诊断、病理/分子诊断，分期和危险分层，治疗，个体化医, cover=https://img.medsci.cn/20201130/1606749603869_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Thu Nov 12 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，欧洲肿瘤内科学会(ESMO)发布了骨髓增生异常综合征的诊断，治疗和随访指南。指南主要内容涉及骨髓增生异常综合征的发病率和流行病学，诊断、病理/分子诊断，分期和危险分层，治疗，个体化医疗以及随访等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2580, tagName=骨髓增生异常综合征)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2580, guiderKeyword=骨髓增生异常综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4092, appHits=267, showAppHits=0, pcHits=1048, showPcHits=3825, likes=2, shares=13, comments=23, approvalStatus=1, publishedTime=Mon Nov 30 00:29:09 CST 2020, publishedTimeString=2020-11-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 30 23:20:11 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:21:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访.pdf)])
2020 ESMO临床实践指南：骨髓增生异常综合征的诊断，治疗和随访.pdf
下载请点击：
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1203787, encodeId=324b1203e873f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Fri Mar 18 14:04:51 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194921, encodeId=038d119492156, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Feb 18 22:24:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056548, encodeId=ffd010565481d, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:33:06 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052542, encodeId=5dda105254260, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:56:21 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966296, encodeId=6d0b96629674, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:06:29 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2022-03-18 yelinlin

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1203787, encodeId=324b1203e873f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Fri Mar 18 14:04:51 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194921, encodeId=038d119492156, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Feb 18 22:24:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056548, encodeId=ffd010565481d, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:33:06 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052542, encodeId=5dda105254260, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:56:21 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966296, encodeId=6d0b96629674, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:06:29 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2022-02-18 屋顶瞄爱赏月

    学习学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1203787, encodeId=324b1203e873f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Fri Mar 18 14:04:51 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194921, encodeId=038d119492156, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Feb 18 22:24:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056548, encodeId=ffd010565481d, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:33:06 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052542, encodeId=5dda105254260, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:56:21 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966296, encodeId=6d0b96629674, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:06:29 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    谢谢分享。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1203787, encodeId=324b1203e873f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Fri Mar 18 14:04:51 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194921, encodeId=038d119492156, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Feb 18 22:24:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056548, encodeId=ffd010565481d, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:33:06 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052542, encodeId=5dda105254260, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:56:21 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966296, encodeId=6d0b96629674, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:06:29 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-09-18 ms8000000981268929

    及时雨

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1203787, encodeId=324b1203e873f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK0iclWFtP7WicKXLyVXAOnRibMria0BwB4otV2d2ibbbkZ2XKAvnNH5x3Y1wm9ibMNZZV5ib5qA0B99sMpw/132, createdBy=9a062530214, createdName=yelinlin, createdTime=Fri Mar 18 14:04:51 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194921, encodeId=038d119492156, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Fri Feb 18 22:24:15 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056548, encodeId=ffd010565481d, content=谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:33:06 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052542, encodeId=5dda105254260, content=及时雨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:56:21 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966296, encodeId=6d0b96629674, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b3e5495194, createdName=小李..., createdTime=Mon May 17 16:06:29 CST 2021, time=2021-05-17, status=1, ipAttribution=)]
    2021-05-17 小李...

    学习学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-6:骨髓增生异常综合征

日本血液学会(JSH,Japanese Society of Hematology) · 2020-02-14

2019 西班牙指南：靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用

国外血液科相关专家小组 · 2019-10-16

骨髓增生异常综合征中国诊断与治疗指南（2019年）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2019-02-20

2018 专家共识建议：接受积极治疗的骨髓增生异常综合征患者感染控制

国外血液科相关专家小组 · 2018-10-28

2018 加拿大MDS联盟循证指南：骨髓增生异常综合征铁过载

国外血液科相关专家小组 · 2018-09-19

骨髓增生异常综合征中西医结合诊疗专家共识（2018年）

中国中西医结合学会(CAIM,Chinese Association of Integrative Medicine) · 2018-07-20

拓展阅读

骨髓增生异常综合征-难治性贫血伴原始 细胞过多（MDS-RAEB）临床路径

中华人民共和国国家卫生和计划生育委员会(NHFPC,National Health and Family Planning Commission of China) · 2016-04-21

儿童骨髓增生异常综合征诊断与治疗中国专家共识(2015年版)

中华医学会儿科学分会血液学组 · 2016-04-27

骨髓增生异常综合征中西医结合诊疗专家共识（2018年）

中国中西医结合学会(CAIM,Chinese Association of Integrative Medicine) · 2018-07-20

2018 加拿大MDS联盟循证指南：骨髓增生异常综合征铁过载

国外血液科相关专家小组 · 2018-09-19

2018 专家共识建议：接受积极治疗的骨髓增生异常综合征患者感染控制

国外血液科相关专家小组 · 2018-10-28

骨髓增生异常综合征中国诊断与治疗指南（2019年）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2019-02-20

Baidu
map
Baidu
map
Baidu
map